
Targeting The Heart With AI
Cardiologist doctor examine patient heart functions and blood vessel on virtual interface. Medical ... More technology and healthcare treatment to diagnose heart disorder and disease of cardiovascular system.
It's one thing to talk about what AI will do in healthcare – they use cases and applications that will change the face of that field.
It's something else to describe how this will happen – how the body's systems interact with the technology in ways that can, frankly, be pretty amazing.
Our bodies are immensely complex – very sophisticated machines with literally dozens of functional systems put together in a unified whole. That's not to mention the immense structure of the human brain, which Marvin Minsky famously characterized as hundreds of machines working together in his Society of the Mind book, as well as his legacy of work at MIT.
Complex Systems in Human Biology
Just take the heart – the body's largest muscle, and responsible for keeping us alive by pumping blood through the body in particular ways.
With its multiple chambers, its complex system of veins and arteries, its electrical impulses and more, the heart is in some ways enigmatic and difficult for clinicians to work on.
The gold standard for cardiac evaluation is the EKG; at least, it has been for decades.
But what if AI and other technologies could find new ways of getting cardiac information, and new ways of diagnosing and processing it for patient care?
The Equipment of Cardiology
Recently, my colleague, Daniela Rus, director of the MIT CSAIL lab, interviewed SandboxAQ CEO Jack Hidary at Imagination in Action this spring. They talked about specifically that: how quantum technology and artificial intelligence could be used to innovate heart care.
Prior to that, though, Hidary talked about other medical use cases, pointing out, for example, that 85% of clinical trials fail, and that specific strategies with AI can save enormous amounts of time and money in looking at how proteins bind to receptors, or other outcomes.
A Quick Glossary
Prior to going into the specifics of new AI heart treatment Hidary referenced CUDA (Compute Unified Device Architecture) which is a parallel computing platform created by NVIDIA that allows developers to use some of the company's hardware for general-purpose and scientific computing. That's going to be relevant here. He also talks about tensors, in aid of explaining how teams can 'put quantum on GPUs' - he also mentioned quantum sensors, which are new ways to gather information by using quantum science for precision in data handling. That's where this theory on cardiology care comes in.
Replacing the EKG
The EKG assesses the electric field of the heart. A new quantum and AI method, Hidary suggested, would instead focus on the magnetic field of the heart. This could come through the body in a very direct and full way, in order to provide better and more detailed data.
Think of it as a type of lossless signal compression that will deliver better data to cardiac assessment.
'This is something that is melding AI and quantum together,' he said. 'You can't do one without the other.'
Here's how he described the process:
'Your skin conductance is very indirectly related to your heart,' Hidary said. 'Those wires (in the new system) are not on your heart itself. They're on your skin, but the magnetic field comes through the cavity of the body, undisturbed, unperturbed, intact in 360 degrees, (in data) around us that is a beautiful, pristine, high-density information view of the heart, unlike the EKG, which is very indirect and often has many false positives and many, many false negatives.'
In listening to Hidary talk, you get the idea that we may be on the verge of revolutionary new kinds of heart treatments that rely on the intersection of quantum and AI to see what's really happening inside of a person's body.
More on Heart Care
This resource from Campanile Cardiology talks about changing care from reactive to proactive, and using pattern recognition and predictive power for early detection.
The author also covers efforts to figure out the heart's 'real age' or biological age based on conditions like plaque buildup.
Or you can take this set of predictions from JACC, notwithstanding the medical-ese in which they're written:
· AI-enabled technologies are increasingly integrated into cardiovascular practice and investigation.
· Over the next decade, we envision an AI-propelled future in which the cardiovascular diagnostic and therapeutic landscape will effectively leverage multimodal data at the point of care.
· Innovations in biomedical discovery and cardiovascular research are also set to make the future of cardiovascular care more personalized, precise, and effective.
· The path to this future requires equitable and regulated adoption that prioritizes fairness, equity, safety, and partnerships with innovators as well as our communities and society.
In any case, it looks like we are close to unlocking new types of healthcare with the technologies at our disposal. And these are brand new.
Five years ago, ten years ago, nobody was writing about these things, because they didn't functionally exist. What we've discovered is a new expanse of uncharted waters. That's going to keep us busy for quite a while.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
9 minutes ago
- Yahoo
Blood test can detect cancer 18 months before symptoms appear
A new blood test means it is now possible to detect cancer up to 18 months before symptoms even appear. Test for Cancer has launched the HrC Genomics blood test, a non-invasive screening tool designed to spot cancer before it becomes symptomatic, reducing the need for invasive procedures like tissue biopsies. With cancer among the world's leading causes of death, early detection remains one of the most effective ways to improve outcomes. But many cancers are diagnosed too late, when treatment options are more limited and survival rates are lower. Test for Cancer says its new test can change that. By identifying specific stem cells that begin circulating when cancer is present, even before symptoms emerge, the HrC Genomics test offers a way to screen for cancer much earlier than standard approaches allow. READ MORE: Cardiologists name two foods that lower cholesterol 'just like statins' READ MORE: Neurologist says you can cut cholesterol, blood pressure and dementia risk in 20 minutes According to the organisation, these cells, known as pluripotent progenitor stem cells, can be detected in the blood as early as 12 to 18 months before any signs of illness. That early window gives patients and doctors more time to intervene and improves the chances of successful treatment. The test is available to adults of all ages and is not limited by gender or family history, making it a potentially powerful screening option for people who might not otherwise qualify for routine checks. Test for Cancer says its mission is to make early cancer detection more widely accessible, helping more people take control of their health and catch cancer before it advances.
Yahoo
17 minutes ago
- Yahoo
Which "Magnificent Seven" Stock Makes the Best Buy for the Second Half?
Tech stocks known as the "Magnificent Seven" led market gains last year. One particular AI leader rose 800% over three years but still has plenty of room to run. 10 stocks we like better than Nvidia › A group of technology stocks, known as the "Magnificent Seven" -- a nod to the 1960 Western -- led stock market gains last year and has started to rebound in recent times. Which one makes the best buy for the second half? The answer to that question is Nvidia (NASDAQ: NVDA), even though the stock has already climbed 800% over the past three years. Let's find out why this top artificial intelligence (AI) stock may still be in the early days of its growth story. Nvidia has played a key role since the first days of the AI boom, and this is because it designs the crucial element that makes AI work: chips. They're known as graphics processing units (GPUs), and they power the fundamental step of training AI models, a process that allows those models to then handle complex tasks and solve real-world problems. So, without these chips, we wouldn't have AI. This helped Nvidia's revenue take off a few years ago, as you can see in the chart below. In Nvidia's earlier days, it primarily served the video gaming market, which resulted in progressive growth, but revenue levels were a far cry from today's AI-driven revenue. This is because companies realize the potential of this technology to save them time and money and even help them develop game-changing products and services, so they're pouring investment into AI. And Nvidia, as the leading chip designer, is benefiting. This potential is further illustrated by forecasts calling for the AI market to reach into the trillions of dollars in a few years from now. Importantly, Nvidia isn't just about GPUs. The company has built an AI empire, creating software and networking tools, and it even aims to power the humanoid robots of tomorrow. This expansion is key to Nvidia's growth because it enables the company to benefit from every stage of AI development -- not just the early days of infrastructure ramp-up. Meanwhile, Nvidia has also put the focus on innovation to ensure it stays ahead of its rivals. It has pledged to update its chips yearly and has already offered investors visibility into planned launches over the coming three years. Though rivals are carving out market share -- for example, Advanced Micro Devices recently reported a 57% increase in data center quarterly revenue -- Nvidia's innovation should keep it in the top spot. The enormous demand for AI means that others, like AMD, can succeed without truly encroaching on Nvidia's territory. The biggest disappointment for Nvidia and investors at this point (and possibly into the future) is the situation concerning exports to China. The U.S. has blocked chip exports, cutting Nvidia out of the market that represented 13% of its revenue last year. This isn't a non-event, and if the situation remains as is, it limits Nvidia's growth opportunities to some degree. The good news is that Nvidia makes most of its revenue in the U.S. and a great deal in other locations as well, so the export situation doesn't necessarily translate to slow growth for this chip giant. All this sounds positive, but why is Nvidia the best Magnificent Seven buy for the second half? Nvidia remains the best overall AI bet due to its deep presence across every stage of the technology's growth. The world's biggest tech companies turn to Nvidia to power their platforms, and that's unlikely to change, as these customers aim to use the fastest processors available -- and those are likely to have the name Nvidia on them well into the future. Nvidia will accompany these customers as they deploy AI agents within their businesses or develop humanoid robots down the road. At the same time, Nvidia's valuation leaves the stock plenty of room to run. Though it's inched higher in recent weeks, it still trades significantly lower than it did just a few months ago, at 36 times forward earnings estimates compared to more than 50 times. All these elements, from Nvidia's presence across AI to its price today, support my prediction that this stock will roar higher in the second half and over the long run, too. Before you buy stock in Nvidia, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Nvidia wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $713,547!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $966,931!* Now, it's worth noting Stock Advisor's total average return is 1,062% — a market-crushing outperformance compared to 177% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 23, 2025 Adria Cimino has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Advanced Micro Devices and Nvidia. The Motley Fool has a disclosure policy. Which "Magnificent Seven" Stock Makes the Best Buy for the Second Half? was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data


WebMD
25 minutes ago
- WebMD
Dating with Bipolar Disorder
Being honest about your mental health can have a really positive impact on your life and the lives of those around you. In my personal experience, the more I've opened up about my bipolar disorder and the struggles that come with it, the better I feel. There's no denying the stigma that still exists around mental illness, but I've found that the best way to combat the related misconceptions is to talk about it. For me, this is especially true in my dating life. I can't remember a time when I haven't made some mention of mental health or my own journey with it once I began dating someone. It's not that I detail my recent hypomanic episode or list out the prescriptions I take, but I do find it helpful and pretty freeing to be transparent about my condition. Doing so gives me the opportunity to give the person I'm seeing more insight into who I am and how I experience the world, to answer questions, and connect with them on an emotional level. It also helps me to suss out how they might handle it as a potential romantic partner. I've been very lucky to have dated partners who were both empathetic and open-minded about my having bipolar disorder. Some have even intervened during an episode, a panic attack, or made sure to text me each day as a reminder to take my medication when I struggled to stay consistent. Not only did these things make me feel reassured and cared for, but they also reaffirmed to me how beneficial it is to communicate about my condition and how it is impacting me. Based on what previous partners have told me, it isn't always easy to love someone who has bipolar disorder. When I first received my diagnosis, it wasn't just my life that was changed: the community of people in my life were impacted, too. This is especially true in the case of spending time or living with a romantic partner. They often have the most intimate connection with you, meaning that they see every facet of who you are up close. Although it was hard for him to admit (and hard for me to process), an ex of mine told me that my hypomanic episodes sometimes scared him. He knew me well enough to recognize when my behavior changed because of hypomania, and while he was proactive about caring for me in those moments, it still affected him emotionally. Rather than getting defensive or taking what he said to heart, I tried to use that conversation as a learning moment. Taking responsibility for my own mental health isn't just for my own benefit. It is also necessary and the least I can do for the people who love and support me. Dating itself isn't always simple. At times, I find that I don't really even enjoy the process of meeting new people on dates. That said, if you — like me — would enjoy having a romantic partnership one day, being open about your mental health is one of the best practices that can lead to a healthy, strong relationship. There is so much strength in vulnerability, so sharing that part of your life with someone you care about is just another way to flex your emotional health 'muscle.'